TrialScientific reports2025

The efficacy of DASH combined with time-restricted feeding (16/8) on metabolic associated fatty liver disease management: a randomized controlled trial.

Maryam Nilghaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.